Spots Global Cancer Trial Database for A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
Official Title: Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis
Study ID: NCT06011824
Conditions
Interventions
Study Description
Brief Summary: Determining if Megakaryocytes and Platelets are Harmful or Helpful in Breast Cancer Cell Metastasis
Detailed Description: The purpose of this study is to determine how megakaryocytes (cells in the bone marrow responsible for making platelets, which are necessary for blood clotting) affect the survival and growth/division patterns of breast cancer stem cells, and the effects of breast cancer cells on megakaryocyte survival and function. Through chart review, the study team will look at the relationship between different blood components and different breast cancer diagnoses.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States
Contact Details
Name: Scott H. Okuno, M.D.
Affiliation: Mayo Clinic Health System-Franciscan Healthcare
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
